-
Oregon removes immigration status as Medicaid coverage obstacle
Medicaid coverage in Oregon is available to all adults and children who meet eligibility criteria — regardless of immigration status — as of July 1. -
Medicare will cover Alzheimer's drug Leqembi: 5 things to know
Medicare will provide broader coverage of Leqembi, a drug that has been shown to slow the progression of Alzheimer's disease, now that the drug has received full FDA approval. -
White House taking aim at surprise medical bills, 'junk' insurance
President Joe Biden announced a series of actions aimed at addressing surprise medical billing, unfair medical debt and "junk" short-term insurance plans. -
CMS updates Medicare drug price negotiation guidelines
CMS published updated guidance for the Medicare Drug Price Negotiation program, based on feedback from more than 7,500 public comments. -
Government watchdog wants CMS to up auditing of Medicaid managed care
The Government Accountability Office is urging CMS to consider adding Medicaid managed care programs to the scope of its recovery audit program. -
The 2-midnight rule and Medicare Advantage: 6 things to know
There are major changes afoot for Medicare Advantage plans in 2024 and when they are required to cover inpatient services in hospitals for their members. The changes are likely to present challenges for hospitals and how physicians document inpatient care. -
California lawmakers reach deal on largest-ever Medicaid investment
California lawmakers and healthcare stakeholders have reached a major deal that represents the largest-ever investment in Medi-Cal, the state's Medicaid program, Politico reported June 24. -
CMS pitches Medicare coverage pathway for new medical devices
CMS is proposing a new pathway for Medicare coverage of new treatments designated as breakthrough devices. -
13 recent CMS moves
From proposed price transparency requirements under Medicaid to a new No Surprises Act website, these are 13 CMS moves reported by Becker's since April 1: -
CMS to states: Slow down Medicaid redeterminations
CMS officials are urging states to double-down on efforts to prevent people from unnecessarily losing Medicaid coverage. -
HHS secretary 'deeply concerned' about procedural Medicaid losses
HHS Secretary Xavier Becerra is urging states to do more to prevent people from losing Medicaid coverage for procedural reasons. -
North Carolina governor approves Blue Cross Blue Shield reorganization
North Carolina Gov. Roy Cooper signed a bill allowing Blue Cross Blue Shield of North Carolina to reorganize as a nonprofit holding company. -
25 more drugs subject to Inflation Reduction Act rebates
HHS has added 25 drugs to its list of products eligible for Inflation Reduction Act rebates. -
FDA commissioner: Agency, CMS discussing Medicare weight loss drug coverage
The FDA and CMS are discussing how to handle obesity drugs in Medicare, Bloomberg Law reported June 7. -
CMS: Medicare will cover Alzheimer's drugs with full FDA approval
Medicare will cover drugs to treat Alzheimer's disease if they receive full FDA approval, the agency said June 1. -
UnitedHealthcare backs off controversial GI prior authorization policy
UnitedHealthcare is not implementing a gastroenterology endoscopy prior authorization policy set to take effect June 1 and instead will set up an advance notification process for non-screening GI procedures. -
North Carolina legislators OK Blue Cross Blue Shield reorganization
North Carolina legislators approved a bill that would allow Blue Cross Blue Shield of North Carolina to reorganize, adding a new nonprofit parent company. -
CMS: 'Substantial' portion of Medicaid terminations due to red tape
With Medicaid redeterminations underway nationwide, CMS is urging states to ensure they do not terminate coverage for eligible individuals. -
Illinois passes bill creating state-run ACA exchange
Illinois lawmakers have passed legislation to create a state-run health insurance exchange. -
7 key CMS policy updates in the first half of 2023
CMS has finalized or proposed several policy changes in 2023, including stricter audits of Medicare Advantage plans, changes to prior authorization and regulations aimed at drug prices.
Page 6 of 50